Cargando…

Comprehensive genomic profile of cholangiocarcinomas in China

Cholangiocarcinoma (CCA) is a primary malignancy, which is often diagnosed as locally advanced or metastatic. Previous studies have revealed genomic characteristics of CCA in Western patients, however comprehensive genomic features of CCA in Chinese patients have not been well understood. To explore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Weijun, Hu, Weiyu, Shi, Xiaoling, Liu, Peng, Ma, Xiang, Zhao, Wei, Qu, Linlin, Zhang, Shuirong, Shi, Weiwei, Liu, Angen, Cao, Jingyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074170/ https://www.ncbi.nlm.nih.gov/pubmed/32256810 http://dx.doi.org/10.3892/ol.2020.11429

Ejemplares similares

Potential application of genomic profiling for the diagnosis and treatment of patients with sarcoma
por: Xu, Libin, et al.
Publicado: (2021)

Comprehensive Multiple Molecular Profile of Epithelial Mesenchymal Transition in Intrahepatic Cholangiocarcinoma Patients
por: Huang, Xiao-Yong, et al.
Publicado: (2014)

Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
por: Zhu, Mengxuan, et al.
Publicado: (2022)

Genomic profiling, prognosis, and potential interventional targets in young and old patients with cholangiocarcinoma
por: Wang, Junhua, et al.
Publicado: (2023)

A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients
por: Zhang, Yingli, et al.
Publicado: (2021)

Comprehensive analysis of DNA methylation and gene expression profiles in cholangiocarcinoma
por: Zhang, Cheng, et al.
Publicado: (2019)

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
por: Murugesan, Karthikeyan, et al.
Publicado: (2021)

Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience
por: Wang, Longrong, et al.
Publicado: (2020)

Molecular profiling reveals potential targets in cholangiocarcinoma
por: Liu, Dan, et al.
Publicado: (2023)

Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test
por: Ishido, Shun, et al.
Publicado: (2023)

Comprehensive Analysis of VCAN Expression Profiles and Prognostic Values in HCC
por: Sun, Guangshun, et al.
Publicado: (2022)

Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes
por: Song, Zimin, et al.
Publicado: (2023)

A comprehensive transcriptomic landscape of cholangiocarcinoma based on bioinformatics analysis from large cohort of patients
por: Li, Hongguang, et al.
Publicado: (2021)

Metabolic syndrome and the risk of cholangiocarcinoma: a hospital-based case–control study in China
por: Xiong, Jianping, et al.
Publicado: (2018)

Intrahepatic Cholangiocarcinoma: Genomic Heterogeneity Between Eastern and Western Patients
por: Cao, Jingyu, et al.
Publicado: (2020)

Comprehensive Genomic Profiling of Rare Tumors in China: Routes to Immunotherapy
por: Wang, Shuhang, et al.
Publicado: (2021)

Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma
por: Li, Hanyu, et al.
Publicado: (2019)

Anticancer Effect of Radix Astragali on Cholangiocarcinoma In Vitro and Its Mechanism via Network Pharmacology
por: Wang, Yixiu, et al.
Publicado: (2020)

RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach
por: Balasubramanian, Brinda, et al.
Publicado: (2021)

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
por: Zhang, Rui, et al.
Publicado: (2021)

Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib
por: Shang, Yanhong, et al.
Publicado: (2020)

Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer
por: Qu, Linlin, et al.
Publicado: (2022)

Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review
por: Elvevi, Alessandra, et al.
Publicado: (2023)

Genome Studies on Nematophagous and Entomogenous Fungi in China
por: Zhang, Weiwei, et al.
Publicado: (2016)

Proteogenomic characterization of cholangiocarcinoma
por: Deng, Mengjie, et al.
Publicado: (2023)

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
por: Farshidfar, Farshad, et al.
Publicado: (2017)

Prognostic value of lymph nodes count on survival of patients with distal cholangiocarcinomas
por: Lin, Hua-Peng, et al.
Publicado: (2018)

Comprehensive drug response profiling and pan-omic analysis identified therapeutic candidates and prognostic biomarkers for Asian cholangiocarcinoma
por: Jamnongsong, Supawan, et al.
Publicado: (2022)

Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram
por: Wu, Zi-You, et al.
Publicado: (2020)

Comprehensive analysis of age‐related somatic mutation profiles in Chinese young lung adenocarcinoma patients
por: Yang, Bo, et al.
Publicado: (2019)

Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review
por: Vij, Mukul, et al.
Publicado: (2022)

Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma
por: Silvestri, Marco, et al.
Publicado: (2023)

Comprehensive genomic analysis of the DUF4228 gene family in land plants and expression profiling of ATDUF4228 under abiotic stresses
por: Yang, Qi, et al.
Publicado: (2020)

Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression
por: Wang, Tingjie, et al.
Publicado: (2022)

Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors
por: Lu, Jia-Cheng, et al.
Publicado: (2019)

Genomic and Transcriptomic Landscape of Tumor Clonal Evolution in Cholangiocarcinoma
por: Chen, Geng, et al.
Publicado: (2020)

Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: IS(ICC)‐applied prediction model
por: Tian, Mengxin, et al.
Publicado: (2020)

CMDB: the comprehensive population genome variation database of China
por: Li, Zhichao, et al.
Publicado: (2022)

Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
por: Cao, Hengsong, et al.
Publicado: (2022)

A Comprehensive Genomic Analysis Constructs miRNA–mRNA Interaction Network in Hepatoblastoma
por: Chen, Tong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_70hnhuj540586nmu0c39d9r8oq